문승환 교수
#종양 핵의학 #신경 핵의학 #일반 핵의학 #핵의학 체내검사 #핵의학 체외검사(방사면역측정)
|
학력
2015.02 성균관대학교 의과대학원 핵의학 박사
2010.02 서울대학교 대학원 핵의학 석사
2006.02 서울대학교 의학과 학사
2010.02 서울대학교 대학원 핵의학 석사
2006.02 서울대학교 의학과 학사
경력
2018.03 ~현재 삼성서울병원 핵의학과 조교수
2011.02 ~현재 핵의학과 전문의 취득
2008.12 ~현재 방사성동위원소취급자특수면허 취득
2019.06 ~ 2020.05 University of California, BerKeley 연수
2013.03 ~ 2018.02 삼성서울병원 핵의학과 임상전임강사
2011.03 ~ 2013.02 삼성서울병원 핵의학과 임상강사
2007.03 ~ 2011.02 서울대학교병원 핵의학과 레지던트 과정 수료
2006.03 ~ 2007.02 서울대학교병원 인턴과정 수료
2011.02 ~현재 핵의학과 전문의 취득
2008.12 ~현재 방사성동위원소취급자특수면허 취득
2019.06 ~ 2020.05 University of California, BerKeley 연수
2013.03 ~ 2018.02 삼성서울병원 핵의학과 임상전임강사
2011.03 ~ 2013.02 삼성서울병원 핵의학과 임상강사
2007.03 ~ 2011.02 서울대학교병원 핵의학과 레지던트 과정 수료
2006.03 ~ 2007.02 서울대학교병원 인턴과정 수료
논문
ONCOL REP 2020 10.3892/or.2019.7436
Troglitazone exerts metabolic and antitumor effects on T47D breast cancer cells by suppressing mitochondrial pyruvate availability
Jung1, KH; Lee, JH; Park, JW; Moon, SH; Cho, YS; Lee, KH
PLoS One 2020 10.1371/journal.pone.0228848
Tc-99m-MIBI uptake as a marker of mitochondrial membrane potential in cancer cells and effects of MDR1 and verapamil
Park1, JW; Hong, SP; Lee, JH; Moon, SH; Cho, YS; Jung, KH; Lee, J; Lee, KH
EUR J NUCL MED MOL I 2020 10.1007/s00259-019-04498-y
Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients
Jang1, H; Kim, HJ; Park, S; Park, YH; Choe, Y; Cho, H; Lyoo, CH; Yoon, U; Lee, JS; Kim, Y; Kim, SJ; Kim, JP; Jung, YH; Ryu, YH; Choi, JY; Moon, SH; Seong, JK; DeCarli, C; Weiner, MW; Lockhart, SN; Cho, SH; Na, DL; Seo, SW
EUR J NUCL MED MOL I 2019 10.1007/s00259-019-04663-3
Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes
Kim1, JP; Kim, J; Kim, Y; Moon, SH; Park, YH; Yoo, S; Jang, H; Kim, HJ; Na, DL; Seo, SW; Seong, JK
EUR RADIOL 2019 10.1007/s00330-019-06128-5
Comparison of prognostic values of primary tumor and nodal F-18-fluorodeoxyglucose uptake in non-small cell lung cancer with N1 disease
Lim1, CH; Hyun, SH; Moon, SH; Cho, YS; Choi, JY; Lee, KH
EUR J NUCL MED MOL I 2019 10.1007/s00259-019-04387-4
Diagnostic value of surveillance F-18-fluorodeoxyglucose PET/CT for detecting recurrent esophageal carcinoma after curative treatment
Kim1, SJ; Hyun, SH; Moon, SH; Lee, KS; Sun, JM; Oh, D; Ahn, YC; Zo, JI; Shim, YM; Choi, JY
BMC NEUROL 2019 10.1186/s12883-019-1434-z
THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report
Kim1, HJ; Cho, H; Park, S; Jang, H; Ryu, YH; Choi, JY; Moon, SH; Oh, SJ; Oh, M; Na, DL; Lyoo, CH; Kim, EJ; Seeley, WW; Kim, JS; Choi, KC; Seo, SW
SCI REP-UK 2019 10.1038/s41598-019-48674-4
Predictive and Prognostic Value of F-18-fluorodeoxyglucose Uptake Combined with Thymidylate Synthase Expression in Patients with Advanced Non-Small Cell Lung Cancer
Moon1, SH; Sun, JM; Ahn, JS; Park, K; Kim, BT; Lee, KH; Ahn, MJ; Choi, JY
EUR J NUCL MED MOL I 2019 10.1007/s00259-019-04327-2
Prognostic value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with combined hepatocellular-cholangiocarcinoma
Lim1, CH; Moon, SH; Cho, YS; Choi, JY; Lee, KH; Hyun, SH
EUR RADIOL 2019 10.1007/s00330-018-5764-9
PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients
Lim1, CH; Ahn, TR; Moon, SH; Cho, YS; Choi, JY; Kim, BT; Lee, KH
SCI REP-UK 2019 10.1038/s41598-019-42954-9
ATP-binding Cassette Transporters Substantially Reduce Estimates of ALDH-positive Cancer Cells based on Aldefluor and AldeRed588 Assays
Park1, JW; Jun, KH; Byun, Y; Lee, JH; Moon, SH; Cho, YS; Lee, KH
CLIN RADIOL 2019 10.1016/j.crad.2018.12.010
Evaluation of a diagnostic F-18-FDG PET/CT strategy for differentiating benign from malignant retroperitoneal soft-tissue masses
Lim1, CH; Seok, HY; Hyun, SH; Moon, SH; Cho, YS; Lee, KH; Kim, BT; Choi, JY
EUR J NUCL MED MOL I 2019 10.1007/s00259-018-4138-5
Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer
Moon1, SH; Kim, J; Joung, JG; Cha, H; Park, WY; Ahn, JS; Ahn, MJ; Park, K; Choi, JY; Lee, KH; Kim, BT; Lee, SH
CLIN NUCL MED 2019 10.1097/RLU.0000000000002394
Pretreatment Tumor 18F-FDG Uptake Improves Risk Stratification Beyond RECIST 1.1 in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer FDG Uptake and Risk Stratification
Moon1, SH; Sun, JM; Ahn, JS; Park, K; Ahn, MJ; Choi, JY
Alzheimers Res Ther 2018 10.1186/s13195-018-0432-5
The impact of education on cortical thickness in amyloid-negative subcortical vascular dementia: cognitive reserve hypothesis
Jung1, NY; Cho, H; Kim, YJ; Kim, HJ; Lee, JM; Park, S; Kim, ST; Kim, EJ; Kim, JS; Moon, SH; Lee, JH; Ewers, M; Na, DL; Seo, SW
J ALZHEIMERS DIS 2018 10.3233/JAD-180394
Vascular Effects on Depressive Symptoms in Cognitive Impairment
Kim1, Y; Jang, H; Kim, SJ; Cho, SH; Kim, SE; Kim, ST; Kim, HJ; Moon, SH; Ewers, M; Im, K; Kwon, H; Na, DL; Seo, SW
JAMA NEUROL 2018 10.1001/jamaneurol.2018.0975
Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using F-18-AV1451 Positron Emission Tomography Imaging
Kim1, HJ; Park, S; Cho, H; Jang, YK; Lee, JS; Jang, H; Kim, Y; Kim, KW; Ryu, YH; Choi, JY; Moon, SH; Weiner, MW; Jagust, WJ; Rabinovici, GD; DeCarli, C; Lyoo, CH; Na, DL; Seo, SW
SCI REP-UK 2018 10.1038/s41598-018-29642-w
Reporter PET Images Bortezomib Treatment-Mediated Suppression of Cancer Cell Proteasome Activity
Lee1, JH; Jung, KH; Quach, CHT; Park, JW; Moon, SH; Cho, YS; Lee, KH
EUR J NUCL MED MOL I 2018 10.1007/s00259-018-3975-6
Preoperative [F-18]FDG PET/CT tumour heterogeneity index in patients with uterine leiomyosarcoma: a multicentre retrospective study
Lee1, JW; Park, JY; Lee, HJ; Lee, JJ; Moon, SH; Kang, SY; Cheon, GJ; Chung, HH
ONCOL LETT 2018 10.3892/ol.2018.8471
Targeted therapy of triple negative MDA-MB-468 breast cancer with curcumin delivered by epidermal growth factor-conjugated phospholipid nanoparticles
Jung1, KH; Lee, JH; Park, JW; Kim, DH; Moon, SH; Cho, YS; Lee, KH
KOREAN J RADIOL 2018 10.3348/kjr.2018.19.3.481
Prognostic Value of Baseline F-18-Fluorodeoxyglucose PET/CT in Patients with Multiple Myeloma: A Multicenter Cohort Study
Moon1, SH; Choi, WH; Yoo, IR; Lee, SJ; Paeng, JC; Jeong, SY; Lee, SW; Kim, K; Choi, JY
PLoS One 2018 10.1371/journal.pone.0196808
Role of F-18-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis
Park1, SB; Park, JM; Moon, SH; Cho, YS; Sun, JM; Kim, BT; Lee, KH
EUR J NUCL MED MOL I 2018 10.1007/s00259-017-3876-0
Head to head comparison of [F-18] AV-1451 and [F-18] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia
Jang1, YK; Lyoo, CH; Park, S; Oh, SJ; Cho, H; Oh, M; Ryu, YH; Choi, JY; Rabinovici, GD; Kim, HJ; Moon, SH; Jang, H; Lee, JS; Jagust, WJ; Na, DL; Kim, JS; Seo, SW
SCI REP-UK 2017 10.1038/s41598-017-16236-1
Centiloid method evaluation for amyloid PET of subcortical vascular dementia
Yun1, HJ; Moon, SH; Kim, HJ; Lockhart, SN; Choe, YS; Lee, KH; Na, DL; Lee, JM; Seo, SW
ONCOTARGET 2017 10.18632/oncotarget.19544
Inhibition of aldehyde dehydrogenase 1 enhances the cytotoxic effect of retinaldehyde on A549 cancer cells
Park1, JW; Jung, KH; Lee, JH; Moon, SH; Cho, YS; Lee, KH
SCI REP-UK 2017 10.1038/s41598-017-13370-8
Diagonal Earlobe Crease is a Visible Sign for Cerebral Small Vessel Disease and Amyloid-beta
Lee1, JS; Park, S; Kim, HJ; Kim, Y; Jang, H; Kim, KW; Rhee, HY; Yoon, SS; Hwang, KJ; Park, KC; Moon, SH; Kim, ST; Lockhart, SN; Na, DL; Seo, SW
EUR J NUCL MED MOL I 2017 10.1007/s00259-017-3705-5
Strong association of epidermal growth factor receptor status with breast cancer FDG uptake
Lee1, J; Lee, EJ; Moon, SH; Kim, S; Hyun, SH; Cho, YS; Choi, JY; Kim, BT; Lee, KH
Leuk Lymphoma. 2017 Jun;58(6):1341-1348. doi: 10.1080/10428194.2016.1236380. Epub 2016 Oct 9.
Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma
Moon SH11, Lee AY1, Kim WS2, Kim SJ2, Cho YS1, Choe YS1, Kim BT1, Lee KH1.
JOURNAL OF GYNECOLOGIC ONCOLOGY, MAY 2017, 28(3), DOI: 10.3802/jgo.2017.28.e28
Prognostic significance of preoperative F-18-FDG PET/CT in uterine leiomyosarcoma
Park JY1, Lee JW, Lee HJ, Lee JJ, Moon SH, Kang SY, Cheon GJ, Chung HH
J Alzheimers Dis. 2017;57(3):711-716. doi: 10.3233/JAD-161139.
F-18-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy
Kim HJ11,2, Cho H3, Werring DJ4, Jang YK1,2, Kim YJ1,2,5, Lee JS6, Lee J1,2,7, Jun S1,2, Park S1,2, Ryu YH8, Choi JY8, Cho YS9, Moon SH9, Na DL1,2,10, Lyoo CH3, Seo SW1,2,10,11.
Troglitazone exerts metabolic and antitumor effects on T47D breast cancer cells by suppressing mitochondrial pyruvate availability
Jung1, KH; Lee, JH; Park, JW; Moon, SH; Cho, YS; Lee, KH
PLoS One 2020 10.1371/journal.pone.0228848
Tc-99m-MIBI uptake as a marker of mitochondrial membrane potential in cancer cells and effects of MDR1 and verapamil
Park1, JW; Hong, SP; Lee, JH; Moon, SH; Cho, YS; Jung, KH; Lee, J; Lee, KH
EUR J NUCL MED MOL I 2020 10.1007/s00259-019-04498-y
Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients
Jang1, H; Kim, HJ; Park, S; Park, YH; Choe, Y; Cho, H; Lyoo, CH; Yoon, U; Lee, JS; Kim, Y; Kim, SJ; Kim, JP; Jung, YH; Ryu, YH; Choi, JY; Moon, SH; Seong, JK; DeCarli, C; Weiner, MW; Lockhart, SN; Cho, SH; Na, DL; Seo, SW
EUR J NUCL MED MOL I 2019 10.1007/s00259-019-04663-3
Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes
Kim1, JP; Kim, J; Kim, Y; Moon, SH; Park, YH; Yoo, S; Jang, H; Kim, HJ; Na, DL; Seo, SW; Seong, JK
EUR RADIOL 2019 10.1007/s00330-019-06128-5
Comparison of prognostic values of primary tumor and nodal F-18-fluorodeoxyglucose uptake in non-small cell lung cancer with N1 disease
Lim1, CH; Hyun, SH; Moon, SH; Cho, YS; Choi, JY; Lee, KH
EUR J NUCL MED MOL I 2019 10.1007/s00259-019-04387-4
Diagnostic value of surveillance F-18-fluorodeoxyglucose PET/CT for detecting recurrent esophageal carcinoma after curative treatment
Kim1, SJ; Hyun, SH; Moon, SH; Lee, KS; Sun, JM; Oh, D; Ahn, YC; Zo, JI; Shim, YM; Choi, JY
BMC NEUROL 2019 10.1186/s12883-019-1434-z
THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report
Kim1, HJ; Cho, H; Park, S; Jang, H; Ryu, YH; Choi, JY; Moon, SH; Oh, SJ; Oh, M; Na, DL; Lyoo, CH; Kim, EJ; Seeley, WW; Kim, JS; Choi, KC; Seo, SW
SCI REP-UK 2019 10.1038/s41598-019-48674-4
Predictive and Prognostic Value of F-18-fluorodeoxyglucose Uptake Combined with Thymidylate Synthase Expression in Patients with Advanced Non-Small Cell Lung Cancer
Moon1, SH; Sun, JM; Ahn, JS; Park, K; Kim, BT; Lee, KH; Ahn, MJ; Choi, JY
EUR J NUCL MED MOL I 2019 10.1007/s00259-019-04327-2
Prognostic value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with combined hepatocellular-cholangiocarcinoma
Lim1, CH; Moon, SH; Cho, YS; Choi, JY; Lee, KH; Hyun, SH
EUR RADIOL 2019 10.1007/s00330-018-5764-9
PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients
Lim1, CH; Ahn, TR; Moon, SH; Cho, YS; Choi, JY; Kim, BT; Lee, KH
SCI REP-UK 2019 10.1038/s41598-019-42954-9
ATP-binding Cassette Transporters Substantially Reduce Estimates of ALDH-positive Cancer Cells based on Aldefluor and AldeRed588 Assays
Park1, JW; Jun, KH; Byun, Y; Lee, JH; Moon, SH; Cho, YS; Lee, KH
CLIN RADIOL 2019 10.1016/j.crad.2018.12.010
Evaluation of a diagnostic F-18-FDG PET/CT strategy for differentiating benign from malignant retroperitoneal soft-tissue masses
Lim1, CH; Seok, HY; Hyun, SH; Moon, SH; Cho, YS; Lee, KH; Kim, BT; Choi, JY
EUR J NUCL MED MOL I 2019 10.1007/s00259-018-4138-5
Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer
Moon1, SH; Kim, J; Joung, JG; Cha, H; Park, WY; Ahn, JS; Ahn, MJ; Park, K; Choi, JY; Lee, KH; Kim, BT; Lee, SH
CLIN NUCL MED 2019 10.1097/RLU.0000000000002394
Pretreatment Tumor 18F-FDG Uptake Improves Risk Stratification Beyond RECIST 1.1 in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer FDG Uptake and Risk Stratification
Moon1, SH; Sun, JM; Ahn, JS; Park, K; Ahn, MJ; Choi, JY
Alzheimers Res Ther 2018 10.1186/s13195-018-0432-5
The impact of education on cortical thickness in amyloid-negative subcortical vascular dementia: cognitive reserve hypothesis
Jung1, NY; Cho, H; Kim, YJ; Kim, HJ; Lee, JM; Park, S; Kim, ST; Kim, EJ; Kim, JS; Moon, SH; Lee, JH; Ewers, M; Na, DL; Seo, SW
J ALZHEIMERS DIS 2018 10.3233/JAD-180394
Vascular Effects on Depressive Symptoms in Cognitive Impairment
Kim1, Y; Jang, H; Kim, SJ; Cho, SH; Kim, SE; Kim, ST; Kim, HJ; Moon, SH; Ewers, M; Im, K; Kwon, H; Na, DL; Seo, SW
JAMA NEUROL 2018 10.1001/jamaneurol.2018.0975
Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using F-18-AV1451 Positron Emission Tomography Imaging
Kim1, HJ; Park, S; Cho, H; Jang, YK; Lee, JS; Jang, H; Kim, Y; Kim, KW; Ryu, YH; Choi, JY; Moon, SH; Weiner, MW; Jagust, WJ; Rabinovici, GD; DeCarli, C; Lyoo, CH; Na, DL; Seo, SW
SCI REP-UK 2018 10.1038/s41598-018-29642-w
Reporter PET Images Bortezomib Treatment-Mediated Suppression of Cancer Cell Proteasome Activity
Lee1, JH; Jung, KH; Quach, CHT; Park, JW; Moon, SH; Cho, YS; Lee, KH
EUR J NUCL MED MOL I 2018 10.1007/s00259-018-3975-6
Preoperative [F-18]FDG PET/CT tumour heterogeneity index in patients with uterine leiomyosarcoma: a multicentre retrospective study
Lee1, JW; Park, JY; Lee, HJ; Lee, JJ; Moon, SH; Kang, SY; Cheon, GJ; Chung, HH
ONCOL LETT 2018 10.3892/ol.2018.8471
Targeted therapy of triple negative MDA-MB-468 breast cancer with curcumin delivered by epidermal growth factor-conjugated phospholipid nanoparticles
Jung1, KH; Lee, JH; Park, JW; Kim, DH; Moon, SH; Cho, YS; Lee, KH
KOREAN J RADIOL 2018 10.3348/kjr.2018.19.3.481
Prognostic Value of Baseline F-18-Fluorodeoxyglucose PET/CT in Patients with Multiple Myeloma: A Multicenter Cohort Study
Moon1, SH; Choi, WH; Yoo, IR; Lee, SJ; Paeng, JC; Jeong, SY; Lee, SW; Kim, K; Choi, JY
PLoS One 2018 10.1371/journal.pone.0196808
Role of F-18-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis
Park1, SB; Park, JM; Moon, SH; Cho, YS; Sun, JM; Kim, BT; Lee, KH
EUR J NUCL MED MOL I 2018 10.1007/s00259-017-3876-0
Head to head comparison of [F-18] AV-1451 and [F-18] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia
Jang1, YK; Lyoo, CH; Park, S; Oh, SJ; Cho, H; Oh, M; Ryu, YH; Choi, JY; Rabinovici, GD; Kim, HJ; Moon, SH; Jang, H; Lee, JS; Jagust, WJ; Na, DL; Kim, JS; Seo, SW
SCI REP-UK 2017 10.1038/s41598-017-16236-1
Centiloid method evaluation for amyloid PET of subcortical vascular dementia
Yun1, HJ; Moon, SH; Kim, HJ; Lockhart, SN; Choe, YS; Lee, KH; Na, DL; Lee, JM; Seo, SW
ONCOTARGET 2017 10.18632/oncotarget.19544
Inhibition of aldehyde dehydrogenase 1 enhances the cytotoxic effect of retinaldehyde on A549 cancer cells
Park1, JW; Jung, KH; Lee, JH; Moon, SH; Cho, YS; Lee, KH
SCI REP-UK 2017 10.1038/s41598-017-13370-8
Diagonal Earlobe Crease is a Visible Sign for Cerebral Small Vessel Disease and Amyloid-beta
Lee1, JS; Park, S; Kim, HJ; Kim, Y; Jang, H; Kim, KW; Rhee, HY; Yoon, SS; Hwang, KJ; Park, KC; Moon, SH; Kim, ST; Lockhart, SN; Na, DL; Seo, SW
EUR J NUCL MED MOL I 2017 10.1007/s00259-017-3705-5
Strong association of epidermal growth factor receptor status with breast cancer FDG uptake
Lee1, J; Lee, EJ; Moon, SH; Kim, S; Hyun, SH; Cho, YS; Choi, JY; Kim, BT; Lee, KH
Leuk Lymphoma. 2017 Jun;58(6):1341-1348. doi: 10.1080/10428194.2016.1236380. Epub 2016 Oct 9.
Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma
Moon SH11, Lee AY1, Kim WS2, Kim SJ2, Cho YS1, Choe YS1, Kim BT1, Lee KH1.
JOURNAL OF GYNECOLOGIC ONCOLOGY, MAY 2017, 28(3), DOI: 10.3802/jgo.2017.28.e28
Prognostic significance of preoperative F-18-FDG PET/CT in uterine leiomyosarcoma
Park JY1, Lee JW, Lee HJ, Lee JJ, Moon SH, Kang SY, Cheon GJ, Chung HH
J Alzheimers Dis. 2017;57(3):711-716. doi: 10.3233/JAD-161139.
F-18-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy
Kim HJ11,2, Cho H3, Werring DJ4, Jang YK1,2, Kim YJ1,2,5, Lee JS6, Lee J1,2,7, Jun S1,2, Park S1,2, Ryu YH8, Choi JY8, Cho YS9, Moon SH9, Na DL1,2,10, Lyoo CH3, Seo SW1,2,10,11.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.